Also worth noting is that the genetech proposed deal pending the superbug 'holy grail' of 142mil is just that, that of pertaining to the in house results ending the twelve month period soon.., ofcourse subject to a further twelve month period, if taken by genetech, some sort of funding will follow to pyc.
That said, and boy that was a mouthful, the onocology programme with the anticipated validation studies pending, has not yet excited any licensing deals.., umm, think about it..luck to all holders.
Also worth noting is that the genetech proposed deal pending the...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.27 |
Change
0.005(0.40%) |
Mkt cap ! $740.7M | |||
| Open | High | Low | Value | Volume |
| $1.27 | $1.29 | $1.27 | $406.0K | 319.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 13987 | $1.27 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.29 | 1380 | 1 |
View Market Depth
| Last trade - 16.10pm 27/06/2025 (20 minute delay) ? |
| PYC (ASX) Chart |